| R-HSA-111885 |
Opioid Signalling |
| R-HSA-111932 |
CaMK IV-mediated phosphorylation of CREB |
| R-HSA-111933 |
Calmodulin induced events |
| R-HSA-111996 |
Ca-dependent events |
| R-HSA-111997 |
CaM pathway |
| R-HSA-112040 |
G-protein mediated events |
| R-HSA-112043 |
PLC beta mediated events |
| R-HSA-112314 |
Neurotransmitter receptors and postsynaptic signal transmission |
| R-HSA-112314 |
Neurotransmitter receptors and postsynaptic signal transmission |
| R-HSA-112315 |
Transmission across Chemical Synapses |
| R-HSA-112315 |
Transmission across Chemical Synapses |
| R-HSA-112316 |
Neuronal System |
| R-HSA-112316 |
Neuronal System |
| R-HSA-1280215 |
Cytokine Signaling in Immune system |
| R-HSA-1489509 |
DAG and IP3 signaling |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-1643685 |
Disease |
| R-HSA-168256 |
Immune System |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-2262752 |
Cellular responses to stress |
| R-HSA-3371556 |
Cellular response to heat stress |
| R-HSA-3371571 |
HSF1-dependent transactivation |
| R-HSA-372790 |
Signaling by GPCR |
| R-HSA-382551 |
Transport of small molecules |
| R-HSA-388396 |
GPCR downstream signalling |
| R-HSA-397014 |
Muscle contraction |
| R-HSA-399719 |
Trafficking of AMPA receptors |
| R-HSA-399721 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity |
| R-HSA-418594 |
G alpha (i) signalling events |
| R-HSA-438064 |
Post NMDA receptor activation events |
| R-HSA-438066 |
Unblocking of NMDA receptors, glutamate binding and activation |
| R-HSA-438066 |
Unblocking of NMDA receptors, glutamate binding and activation |
| R-HSA-442729 |
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde |
| R-HSA-442742 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling |
| R-HSA-442755 |
Activation of NMDA receptors and postsynaptic events |
| R-HSA-442755 |
Activation of NMDA receptors and postsynaptic events |
| R-HSA-442982 |
Ras activation upon Ca2+ influx through NMDA receptor |
| R-HSA-5576891 |
Cardiac conduction |
| R-HSA-5576892 |
Phase 0 - rapid depolarisation |
| R-HSA-5578775 |
Ion homeostasis |
| R-HSA-5663202 |
Diseases of signal transduction by growth factor receptors and second messengers |
| R-HSA-5673000 |
RAF activation |
| R-HSA-5673001 |
RAF/MAP kinase cascade |
| R-HSA-5683057 |
MAPK family signaling cascades |
| R-HSA-5684996 |
MAPK1/MAPK3 signaling |
| R-HSA-6802946 |
Signaling by moderate kinase activity BRAF mutants |
| R-HSA-6802949 |
Signaling by RAS mutants |
| R-HSA-6802952 |
Signaling by BRAF and RAF fusions |
| R-HSA-6802955 |
Paradoxical activation of RAF signaling by kinase inactive BRAF |
| R-HSA-6802957 |
Oncogenic MAPK signaling |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-877300 |
Interferon gamma signaling |
| R-HSA-8953897 |
Cellular responses to external stimuli |
| R-HSA-8986944 |
Transcriptional Regulation by MECP2 |
| R-HSA-9006925 |
Intracellular signaling by second messengers |
| R-HSA-9022692 |
Regulation of MECP2 expression and activity |
| R-HSA-913531 |
Interferon Signaling |
| R-HSA-936837 |
Ion transport by P-type ATPases |
| R-HSA-9607240 |
FLT3 Signaling |
| R-HSA-9609736 |
Assembly and cell surface presentation of NMDA receptors |
| R-HSA-9617324 |
Negative regulation of NMDA receptor-mediated neuronal transmission |
| R-HSA-9620244 |
Long-term potentiation |
| R-HSA-9649948 |
Signaling downstream of RAS mutants |
| R-HSA-9656223 |
Signaling by RAF1 mutants |
| R-HSA-983712 |
Ion channel transport |
